Aflatoxin and outcome from acute lower respiratory infection in children in The Philippines.
Aflatoxin is immunosuppressive in experimental conditions. This study addressed its potentially contributory role in the poor outcome of acute lower respiratory infections (ALRI) in children in The Philippines. The catchment area included peri-urban slums and middle-class housing. One hundred and fifteen children (mean age 2.1, range 0.08-12 years) were enrolled and their serum and urine obtained at presentation with ALRI. Aflatoxins in serum and aflatoxin metabolites in urine were measured by previously validated ELISA tests. Using the 1986 WHO criteria for the severity of ALRI, 31% had mild, 12% moderate, 49% severe and 8% severe complicated pneumonia. Eighty of 97 (82%) chest radiographs were abnormal. Ninety per cent of the children were below average weight for age, using Filipino standards, with a mean of 79% (range 27-157%). Thirteen (11%) children died. Aflatoxin in their serum, reflecting recent ingestion, was detected in 33%, with a mean positive value of 462 pg/ml. Aflatoxin metabolites (reflecting chronic ingestion) were detected in 64 of 65 urines collected, with a mean value of 0.1-4.77ng/ml. None of the children with detectable serum aflatoxin died. Anorexia and impaired consciousness were strongly associated with a poor outcome (prolonged fever or death). There was a strong association between undetectable serum aflatoxin concentrations and death (p = 0.004), perhaps reflecting anorexia. There was no relationship between the concentration of urinary aflatoxin metabolites and outcome. Serum was also obtained from 29 mothers on admission and none contained detectable aflatoxin. As virtually all the children had evidence of exposure to aflatoxin, a potentially immunosuppressive role in the context of pneumonia cannot be excluded.
Lister Unit, Northwick Park Hospital, Harrow, UK.
D W
DW
Denning
S C
SC
Quiepo
D G
DG
Altman
K
K
Makarananda
G E
GE
Neal
E L
EL
Camallere
M R
MR
Morgan
T E
TE
Tupasi
D000348:Aflatoxins / Q000008:administration & dosage / Q000493:pharmacokinetics; D002423:Cause of Death; D002648:Child; D002675:Child, Preschool; D003906:Developing Countries; D005260:Female; D005506:Food Contamination; D005517:Foodborne Diseases / Q000150:complications* / Q000276:immunology / Q000401:mortality; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007223:Infant; D008297:Male; D010679:Philippines; D011014:Pneumonia / Q000139:chemically induced / Q000276:immunology / Q000401:mortality; D011204:Poverty Areas; D012141:Respiratory Tract Infections / Q000139:chemically induced* / Q000276:immunology / Q000401:mortality; D015996:Survival Rate; D016896:Treatment Outcome; D000096702:Aflatoxin Poisoning
D000348:Aflatoxins